GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Sub Class | LM ID | Common Name ▼ | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:1(17Z))
|
1714.028077
|
C84H151N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:1(17Z))
|
2079.160276
|
C98H174N4O42
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:1(17Z))
|
1714.028077
|
C84H151N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:0)
|
1716.043727
|
C84H153N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:0)
|
2081.175926
|
C98H176N4O42
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/26:0)
|
1716.043727
|
C84H153N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/24:1(15Z))
|
1685.996777
|
C82H147N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/24:1(15Z))
|
2051.128976
|
C96H170N4O42
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/24:1(15Z))
|
1685.996777
|
C82H147N3O32
|
|||||
|
Galb1-4GlcNAcb1-3Galb1-4Glc- (Neolacto series)
|
type II A antigen(d18:1/24:0)
|
1688.012427
|
C82H149N3O32
|
Displaying entries 81 - 90 of 2337 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
